CannaPharmaRX, Inc.
CPMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.42M
Close$
Share Statistics
| Market cap | $1.42 Million |
|---|---|
| Enterprise Value | $22.09 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.02 |
| Beta | 0.47 |
| Outstanding Shares | 682,482,306 |
Return
| Return on Equity | 36.71% |
|---|---|
| Return on Assets | -164.22% |
| Return on Invested Capital | 30.47% |
Valuation & Multiples
| P/E Ratio | -0.12 |
|---|---|
| PEG | -0.33 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 13 |
| Enterprise Value to EBIT | -2.82 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.94 |
| Debt to Equity | -0.67 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About CannaPharmaRX, Inc.
26 employees
CEO: Constantine Nkafu CannaPharmaRX, Inc. is a Canadian enterprise actively involved in the cannabis sector. The company focuses on identifying, acquiring, and developing diverse projects for cultivating cannabis. Founded in 1998, its main offices are located in Calgary, Canada.